Soy Compound May Bolster Women's Bones

Genistein, Found in Soy, May Boost Bone Density in Postmenopausal Women With Osteopenia

Medically Reviewed by Louise Chang, MD on June 18, 2007

June 18, 2007 -- Genistein, a compound found in soy, may strengthen the bones of women at risk for osteoporosis.

So say Italian researchers including Francesco Squadrito, MD, of Italy's University of Messina.

They studied 389 postmenopausal Italian women with osteopenia, in which bone mineral density is less than ideal but not as severe as osteoporosis.

First, the women got DEXA (dual X-ray absorptiometry) bone mineral density scans of their upper thigh bone (femoral neck) and lower (lumbar) spine. Next, they followed a low-fat, healthy diet for a month. Then the researchers split the women into two groups.

One group of women got pills containing genistein, calcium carbonate, and vitamin D. The dosage was "similar to that in vegetarian Asian diets," write the researchers.

The other group received similar pills without genistein (placebo). The women took their pills daily for two years without knowing if the tablets contained genistein.

During that time, the women got annual DEXA scans of their femoral neck and lumbar spine. They were evaluated every three months for problems including breast tenderness, hot flashes, depression, gastrointestinal symptoms, irritability, insomnia, and vaginal bleeding.

Better Bone Density


After two years, the DEXA scans showed increases in bone mineral density in women taking genistein.

Bone mineral density dropped during the same period in women taking the placebo pills.

The researchers didn't gather information on fractures, so they're not sure if genistein's effects mean fewer fractured or broken bones.

Genistein's chemical structure resembles estrogen, the female sex hormone that protects bones and fades after menopause, the researchers note in the Annals of Internal Medicine.

Because of those estrogen-like properties, "caution is needed when administering genistein, especially in patients at high risk for endometrial or breast cancer," write Squadrito and colleagues.

However, the study shows that the uterus lining (endometrium) wasn't thicker in women taking genistein than in those taking the placebo.

Gastrointestinal side effects caused 37 women taking genistein and 15 taking the placebo to quit the study.

Based on the results, Squadrito's team calls for studies testing genistein against osteoporosis.


Show Sources

SOURCES: Marini, H. Annals of Internal Medicine, June 19, 2007; vol 146: pp 839-847. News release, American College of Physicians.

© 2007 WebMD, Inc. All rights reserved. View privacy policy and trust info